Jeffrey Bratberg, Pharm.D., FAPhA

Research Website



Dr. Bratberg is well acquainted with the challenges community pharmacists and pharmacies face regarding opioid safety, overdose, harm reduction, and addiction pharmacotherapy. In 2012, Dr. Bratberg, along with a URI student pharmacist, co-developed an overdose education and naloxone training program for pharmacists in the first-in-nation statewide Collaborative Pharmacy Practice Agreement for naloxone.  

He is an unpaid consultant for and, websites devoted to opioid overdose education and naloxone training for health professionals, community members, and health departments. In 2015, he was selected to serve as a member of the RI Governor’s Overdose Prevention and Intervention Task Force, to create and implement a plan that addresses prevention, treatment, overdose reversal, and recovery of citizens affected by opioid use disorders.

He has been a consultant or co-investigator on federal grants from NIDA, CDC, AHRQ, NIGMS, RI EOHHS, and the URI Foundation. Dr. Bratberg is the 2016 NASPA National Cardinal Health Generation Rx Award winner. The Generation Rx Champions Award honors a pharmacist who has demonstrated outstanding commitment to raising awareness of the dangers of prescription drug misuse among the general public, as well as the pharmacy community. Finally, Dr. Bratberg is the guest editor of the first ever Special Issue on Opioid Safety and Naloxone of the Journal of the American Pharmacists Association (Mar/April 2017).


Opioid Safety, Overdose Prevention, Harm Reduction, Medications for Addiction Treatment (MAT), Public Health, Immunizations, Pharmacy Advocacy


B.S. Pharmaceutical Sciences, North Dakota State University (NDSU), 1998
Minors in Microbiology and Chemistry

Doctor of Pharmacy, NDSU, 2000

PGY1 Pharmacy Practice Residency, Froedtert Hospital, 2001

PGY2 Infectious Diseases/Critical Care Residency, Henry Ford Hospital, 2002

Fellow, American Pharmacists Association, 2019